ATP13A4 amplification has been frequently observed in patients with non‐small‐cell lung cancer ovarian cancer, cervical cancer, head and neck cancer, endometrial cancer, uterine endometrioid carcinoma, bladder cancer, melanoma, and breast cancer [17]. This evidence concerns the gene ATP13A4 and urinary bladder cancer.